Thioridazine inhibits angiogenesis and tumor growth by targeting the VEGFR-2/PI3K/mTOR pathway in ovarian cancer xenografts.

PubWeight™: 0.95‹?› | Rank: Top 15%

🔗 View Article (PMC 4148111)

Published in Oncotarget on July 15, 2014

Authors

Mi Sun Park1, Seung Myung Dong, Boh-Ram Kim, Seung Hee Seo, Sokbom Kang, Eun-Ju Lee, Seung-Hoon Lee, Seung Bae Rho1

Author Affiliations

1: Research Institute, National Cancer Center, 323, Ilsan-ro, Ilsandong-gu, Goyang-si Gyeonggi-do, Republic of Korea.

Articles citing this

PIK3CA and PIK3CB expression and relationship with multidrug resistance in colorectal carcinoma. Int J Clin Exp Pathol (2014) 0.88

Codelivery of thioridazine and doxorubicin using nanoparticles for effective breast cancer therapy. Int J Nanomedicine (2016) 0.78

ZLM-7 exhibits anti-angiogenic effects via impaired endothelial cell function and blockade of VEGF/VEGFR-2 signaling. Oncotarget (2016) 0.76

Penfluridol Represses Integrin Expression in Breast Cancer through Induction of Reactive Oxygen Species and Downregulation of Sp Transcription Factors. Mol Cancer Ther (2016) 0.76

The Ticking of the Epigenetic Clock: Antipsychotic Drugs in Old Age. Front Endocrinol (Lausanne) (2016) 0.75

Thioridazine Sensitizes Esophageal Carcinoma Cell Lines to Radiotherapy-Induced Apoptosis In Vitro and In Vivo. Med Sci Monit (2016) 0.75

Thioridazine has potent antitumor effects on lung cancer stem-like cells. Oncol Lett (2017) 0.75

Critical role of CDK11(p58) in human breast cancer growth and angiogenesis. BMC Cancer (2015) 0.75

The important application of thioridazine in the endometrial cancer. Am J Transl Res (2016) 0.75

Thioridazine enhances sensitivity to carboplatin in human head and neck cancer cells through downregulation of c-FLIP and Mcl-1 expression. Cell Death Dis (2017) 0.75

Relationship between anti-depressant use and lung cancer survival. Cancer Treat Res Commun (2017) 0.75

NOX4-mediated ROS production induces apoptotic cell death via down-regulation of c-FLIP and Mcl-1 expression in combined treatment with thioridazine and curcumin. Redox Biol (2017) 0.75

Articles cited by this

Mechanisms of angiogenesis. Nature (1997) 18.04

Angiogenesis. J Biol Chem (1992) 11.29

Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1/eIF4E. Genes Dev (2002) 8.31

Rapamycin induces feedback activation of Akt signaling through an IGF-1R-dependent mechanism. Oncogene (2006) 6.54

VEGF and the quest for tumour angiogenesis factors. Nat Rev Cancer (2002) 5.96

Role of vascular endothelial growth factor in regulation of physiological angiogenesis. Am J Physiol Cell Physiol (2001) 3.84

Phosphatidylinositol 3-kinase signaling mediates angiogenesis and expression of vascular endothelial growth factor in endothelial cells. Proc Natl Acad Sci U S A (2000) 3.40

Apoptosis defects and chemotherapy resistance: molecular interaction maps and networks. Oncogene (2004) 2.36

PI3K/PTEN signaling in tumorigenesis and angiogenesis. Biochim Biophys Acta (2007) 1.88

Expression of vascular endothelial growth factor, its receptor, and other angiogenic factors in human breast cancer. Cancer Res (1996) 1.81

Downstream signalling events regulated by phosphatidylinositol 3-kinase activity. Cell Signal (1998) 1.28

Solenopsin, the alkaloidal component of the fire ant (Solenopsis invicta), is a naturally occurring inhibitor of phosphatidylinositol-3-kinase signaling and angiogenesis. Blood (2006) 1.15

Regulation of angiogenesis and tumor growth by p110 alpha and AKT1 via VEGF expression. J Cell Physiol (2006) 1.10

Substitution of C-terminus of VEGFR-2 with VEGFR-1 promotes VEGFR-1 activation and endothelial cell proliferation. Oncogene (2004) 1.05

A gene signature-based approach identifies thioridazine as an inhibitor of phosphatidylinositol-3'-kinase (PI3K)/AKT pathway in ovarian cancer cells. Gynecol Oncol (2010) 1.02

Comparative structure-function analysis of VEGFR-1 and VEGFR-2: What have we learned from chimeric systems? Ann N Y Acad Sci (2003) 0.98

Depression in palliative care: a systematic review. Part 2. Treatment. Palliat Med (2002) 0.94

Fever and sweats in the patient with advanced cancer. Hematol Oncol Clin North Am (2002) 0.92

Thioridazine in the management of cancer-related sweating. J Pain Symptom Manage (1998) 0.88

Anti-angiogenic effects of thioridazine involving the FAK-mTOR pathway. Microvasc Res (2012) 0.88

Correlation between reversing of multidrug resistance and inhibiting of [3H]azidopine photolabeling of P-glycoprotein by newly synthesized dihydropyridine analogues in a human cell line. Cancer Res (1989) 0.87

Endothelial receptor tyrosine kinases involved in blood vessel development and tumor angiogenesis. Adv Exp Med Biol (2000) 0.84

A combined biochemical and cytogenetic study of thioridazine-induced damage to nucleic acids. Mutagenesis (1999) 0.80

Articles by these authors

DeltaNp63alpha and TAp63alpha regulate transcription of genes with distinct biological functions in cancer and development. Cancer Res (2003) 2.46

MicroRNA miR-199a* regulates the MET proto-oncogene and the downstream extracellular signal-regulated kinase 2 (ERK2). J Biol Chem (2008) 2.28

Ionizing radiation enhances matrix metalloproteinase-2 secretion and invasion of glioma cells through Src/epidermal growth factor receptor-mediated p38/Akt and phosphatidylinositol 3-kinase/Akt signaling pathways. Cancer Res (2006) 1.96

PTEN suppresses hyaluronic acid-induced matrix metalloproteinase-9 expression in U87MG glioblastoma cells through focal adhesion kinase dephosphorylation. Cancer Res (2002) 1.88

The clinical significance of hepatic parenchymal metastasis in patients with primary epithelial ovarian cancer. Gynecol Oncol (2008) 1.81

Genome-wide association study of Crohn's disease in Koreans revealed three new susceptibility loci and common attributes of genetic susceptibility across ethnic populations. Gut (2013) 1.79

Prognostic significance of c-Met expression in glioblastomas. Cancer (2009) 1.68

Low level of low-density lipoprotein cholesterol increases hemorrhagic transformation in large artery atherothrombosis but not in cardioembolism. Stroke (2009) 1.63

Incidence of cervical, endometrial, and ovarian cancer in Korea, 1999-2010. J Gynecol Oncol (2013) 1.56

Ras stabilization through aberrant activation of Wnt/β-catenin signaling promotes intestinal tumorigenesis. Sci Signal (2012) 1.56

Residual cancer stem cells after interval cytoreductive surgery following neoadjuvant chemotherapy could result in poor treatment outcomes for ovarian cancer. Onkologie (2010) 1.54

ACE inhibition can improve orthostatic proteinuria associated with nutcracker syndrome. Pediatr Nephrol (2006) 1.52

Atherosclerosis in rheumatoid arthritis: morphologic evidence obtained by carotid ultrasound. Arthritis Rheum (2002) 1.52

Advanced coronary artery calcification and cerebral small vessel diseases in the healthy elderly. Circ J (2010) 1.47

Vascular endothelial growth factor modulates neutrophil transendothelial migration via up-regulation of interleukin-8 in human brain microvascular endothelial cells. J Biol Chem (2002) 1.46

Elevated leukocyte count in asymptomatic subjects is associated with a higher risk for cerebral white matter lesions. Clin Neurol Neurosurg (2010) 1.43

Secondary prevention by stroke subtype: a nationwide follow-up study in 46 108 patients after acute ischaemic stroke. Eur Heart J (2013) 1.41

Antithrombotic drug use, cerebral microbleeds, and intracerebral hemorrhage: a systematic review of published and unpublished studies. Stroke (2010) 1.39

Impact of smoking cessation on the risk of subarachnoid haemorrhage: a nationwide multicentre case control study. J Neurol Neurosurg Psychiatry (2012) 1.38

Prognostic factors of secondary cytoreductive surgery for patients with recurrent epithelial ovarian cancer. J Gynecol Oncol (2009) 1.37

Nerve growth factor induces endothelial cell invasion and cord formation by promoting matrix metalloproteinase-2 expression through the phosphatidylinositol 3-kinase/Akt signaling pathway and AP-2 transcription factor. J Biol Chem (2007) 1.35

Secular trends in ischemic stroke characteristics in a rapidly developed country: results from the Korean Stroke Registry Study (secular trends in Korean stroke). Circ Cardiovasc Qual Outcomes (2012) 1.34

Anti-apoptotic protein TCTP controls the stability of the tumor suppressor p53. FEBS Lett (2010) 1.28

BRCA1 and BRCA2 germline mutations in Korean ovarian cancer patients. J Cancer Res Clin Oncol (2009) 1.28

Branch atheromatous plaque: a major cause of lacunar infarction (high-resolution MRI study). Cerebrovasc Dis Extra (2012) 1.26

Antioxidant effects of fermented red ginseng extracts in streptozotocin- induced diabetic rats. J Ginseng Res (2011) 1.25

Minimizing tumor burden by extensive cytoreductive surgery decreases postoperative venous thromboembolism in ovarian clear cell carcinoma. Arch Gynecol Obstet (2009) 1.24

Hereditary non-polyposis colorectal cancer/Lynch syndrome in Korean patients with endometrial cancer. Jpn J Clin Oncol (2010) 1.23

Embryonic natural orifice transumbilical endoscopic surgery (E-NOTES) for adnexal tumors. Surg Endosc (2009) 1.22

Extents of white matter lesions and increased intraventricular extension of intracerebral hemorrhage. Crit Care Med (2013) 1.21

Arsenic trioxide induces apoptosis through a reactive oxygen species-dependent pathway and loss of mitochondrial membrane potential in HeLa cells. Int J Oncol (2002) 1.21

Stroke awareness decreases prehospital delay after acute ischemic stroke in Korea. BMC Neurol (2011) 1.18

Characteristics of HIV seroprevalence of visitors to public health centers under the national HIV surveillance system in Korea: cross sectional study. BMC Public Health (2009) 1.18

Role of hyaluronan in glioma invasion. Cell Adh Migr (2008) 1.16

Multiple eccrine hidrocystomas associated with Graves' disease. Int J Dermatol (2002) 1.13

Phase II trial of low-dose continuous (metronomic) treatment of temozolomide for recurrent glioblastoma. Neuro Oncol (2010) 1.11

Targeting bladder tumor cells in vivo and in the urine with a peptide identified by phage display. Mol Cancer Res (2007) 1.10

Thioridazine induces apoptosis by targeting the PI3K/Akt/mTOR pathway in cervical and endometrial cancer cells. Apoptosis (2012) 1.08

Increased expression of antioxidant enzymes in radioresistant variant from U251 human glioblastoma cell line. Int J Mol Med (2004) 1.08

Metabolic syndrome as an independent risk factor of silent brain infarction in healthy people. Stroke (2005) 1.08

AGR2, a mucinous ovarian cancer marker, promotes cell proliferation and migration. Exp Mol Med (2011) 1.08

Homeobox Msx1 interacts with p53 tumor suppressor and inhibits tumor growth by inducing apoptosis. Cancer Res (2005) 1.06

Primary chemotherapy for newly diagnosed nonsmall cell lung cancer patients with synchronous brain metastases compared with whole-brain radiotherapy administered first : result of a randomized pilot study. Cancer (2008) 1.05

The association of pre-conization high-risk HPV load and the persistence of HPV infection and persistence/recurrence of cervical intraepithelial neoplasia after conization. Gynecol Oncol (2008) 1.05

Detecting cervical cancer by quantitative promoter hypermethylation assay on cervical scrapings: a feasibility study. Mol Cancer Res (2004) 1.04

Efficacy and safety of combination antiplatelet therapies in patients with symptomatic intracranial atherosclerotic stenosis. Stroke (2011) 1.03

Gynecologic Cancer InterGroup (GCIG) consensus review for clear cell carcinoma of the ovary. Int J Gynecol Cancer (2014) 1.03

DAPk1 inhibits NF-κB activation through TNF-α and INF-γ-induced apoptosis. Cell Signal (2012) 1.03

Practice guidelines for the early detection of cervical cancer in Korea: Korean Society of Gynecologic Oncology and the Korean Society for Cytopathology 2012 edition. J Gynecol Oncol (2013) 1.02

A gene signature-based approach identifies thioridazine as an inhibitor of phosphatidylinositol-3'-kinase (PI3K)/AKT pathway in ovarian cancer cells. Gynecol Oncol (2010) 1.02

Inverse correlation between RASSF1A hypermethylation, KRAS and BRAF mutations in cervical adenocarcinoma. Gynecol Oncol (2007) 1.02

Comparative analysis of collagen membranes for the treatment of implant dehiscence defects. Clin Oral Implants Res (2003) 1.02

Preoperative prediction model of lymph node metastasis in endometrial cancer. Int J Gynecol Cancer (2010) 1.01

Ceria nanoparticles that can protect against ischemic stroke. Angew Chem Int Ed Engl (2012) 1.01

Public awareness of stroke in Korea: a population-based national survey. Stroke (2011) 1.01

Insulin-like growth factor-binding protein-5 (IGFBP-5) acts as a tumor suppressor by inhibiting angiogenesis. Carcinogenesis (2008) 1.01

Clinical and radiologic differences between primary intracerebral hemorrhage with and without microbleeds on gradient-echo magnetic resonance images. Arch Neurol (2004) 1.00

High levels of serum uric acid are associated with silent brain infarction. J Neurol Sci (2010) 1.00

Effect of human placental extract on menopausal symptoms, fatigue, and risk factors for cardiovascular disease in middle-aged Korean women. Menopause (2008) 1.00

Pentraxin 3: a novel and independent prognostic marker in ischemic stroke. Atherosclerosis (2011) 0.99

The cancer/testis antigen CAGE with oncogenic potential stimulates cell proliferation by up-regulating cyclins D1 and E in an AP-1- and E2F-dependent manner. J Biol Chem (2010) 0.99

Curcumin inhibits cell cycle progression of immortalized human umbilical vein endothelial (ECV304) cells by up-regulating cyclin-dependent kinase inhibitor, p21WAF1/CIP1, p27KIP1 and p53. Int J Oncol (2002) 0.99

FAS -1377 G/A polymorphism and the risk of lymph node metastasis in cervical cancer. Cancer Genet Cytogenet (2008) 0.99

Hyperthermic intraperitoneal chemotherapy after extensive cytoreductive surgery in patients with primary advanced epithelial ovarian cancer: interim analysis of a phase II study. Ann Surg Oncol (2009) 0.99

Significant association of metabolic syndrome with silent brain infarction in elderly people. J Neurol (2009) 0.98

Epidemiological characteristics of ovarian cancer in Korea. J Gynecol Oncol (2010) 0.98

The RASSF1A tumor suppressor gene is commonly inactivated in adenocarcinoma of the uterine cervix. Clin Cancer Res (2003) 0.98

Reduced neurogenesis after suppressed inflammation by minocycline in transient cerebral ischemia in rat. J Neurol Sci (2009) 0.97

Contrast-enhanced CT for differentiation of ovarian metastasis from gastrointestinal tract cancer: stomach cancer versus colon cancer. AJR Am J Roentgenol (2006) 0.96

Additional value of MR/PET fusion compared with PET/CT in the detection of lymph node metastases in cervical cancer patients. Eur J Cancer (2009) 0.96

Clinical significance of metabotropic glutamate receptor 5 expression in oral squamous cell carcinoma. Oncol Rep (2007) 0.95

LOXL2 expression is associated with invasiveness and negatively influences survival in breast cancer patients. Breast Cancer Res Treat (2013) 0.95

Risk factors predicting residual disease in subsequent hysterectomy following conization for cervical intraepithelial neoplasia (CIN) III and microinvasive cervical cancer. Gynecol Oncol (2007) 0.95

Cilostazol in Acute Ischemic Stroke Treatment (CAIST Trial): a randomized double-blind non-inferiority trial. Cerebrovasc Dis (2011) 0.94

Hyaluronic acid induces osteopontin via the phosphatidylinositol 3-kinase/Akt pathway to enhance the motility of human glioma cells. Cancer Res (2005) 0.94

Oral administration of human papillomavirus type 16 E7 displayed on Lactobacillus casei induces E7-specific antitumor effects in C57/BL6 mice. Int J Cancer (2006) 0.94

CT findings of clear cell carcinoma of the ovary. J Comput Assist Tomogr (2006) 0.94

Interferon regulatory factor 7 regulates glioma stem cells via interleukin-6 and Notch signalling. Brain (2012) 0.94

CYR61 controls p53 and NF-κB expression through PI3K/Akt/mTOR pathways in carboplatin-induced ovarian cancer cells. Cancer Lett (2011) 0.94

Geldanamycin protects rat brain through overexpression of HSP70 and reducing brain edema after cerebral focal ischemia. Neurol Res (2008) 0.93

Immune activation by siRNA/liposome complexes in mice is sequence- independent: lack of a role for Toll-like receptor 3 signaling. Mol Cells (2007) 0.93

Cross-cultural application of the Korean version of the European Organization for Research and Treatment of Cancer quality of life questionnaire cervical cancer module. Oncology (2009) 0.92

Elevated level of SUMOylated IRF-1 in tumor cells interferes with IRF-1-mediated apoptosis. Proc Natl Acad Sci U S A (2007) 0.92

Clinical manifestations in patients with ovarian clear cell carcinoma with or without co-existing endometriosis. Gynecol Endocrinol (2009) 0.92

Association between the location of transposed ovary and ovarian function in patients with uterine cervical cancer treated with (postoperative or primary) pelvic radiotherapy. Fertil Steril (2012) 0.92

The validity of tumour diameter assessed by magnetic resonance imaging and gross specimen with regard to tumour volume in cervical cancer patients. Eur J Cancer (2008) 0.92

The benefits of low anterior en bloc resection as part of cytoreductive surgery for advanced primary and recurrent epithelial ovarian cancer patients outweigh morbidity concerns. Gynecol Oncol (2006) 0.92

The pneumonia score: a simple grading scale for prediction of pneumonia after acute stroke. Am J Infect Control (2006) 0.92

Standardized uptake value of ¹⁸F-fluorodeoxyglucose positron emission tomography for prediction of tumor recurrence in breast cancer beyond tumor burden. Breast Cancer Res (2014) 0.91

Clinical significance of tumor volume in endometrial cancer: a Japan-Korea cooperative study. Gynecol Oncol (2013) 0.91

Programmed cell death 6 (PDCD6) inhibits angiogenesis through PI3K/mTOR/p70S6K pathway by interacting of VEGFR-2. Cell Signal (2011) 0.91

Use of cell culture-PCR assay based on combination of A549 and BGMK cell lines and molecular identification as a tool to monitor infectious adenoviruses and enteroviruses in river water. Appl Environ Microbiol (2004) 0.91

Emodin inhibits vascular endothelial growth factor-A-induced angiogenesis by blocking receptor-2 (KDR/Flk-1) phosphorylation. Int J Cancer (2006) 0.91

MRI for pretreatment lymph node staging in uterine cervical cancer. AJR Am J Roentgenol (2006) 0.91